Cardiovascular
disease remains one of the largest contributors
to death worldwide. Improvements in cardiovascular technology leading
to the current generation of drug-eluting stents, bioresorbable stents,
and drug-eluting balloons, coupled with advances in antirestenotic
therapeutics developed by pharmaceutical community, have had a profound
impact on quality of life and longevity. However, these procedures
and devices contribute to both short- and long-term complications.
Thus, room for improvement and development of new, alternative strategies
exists. Two major approaches have been investigated to improve outcomes
following percutaneous coronary intervention including perivascular
delivery and luminal paving. For both approaches, polymers play a
major role as controlled research vehicles, carriers for cells, and
antithrombotic coatings. With improvements in catheter delivery devices
and increases in our understanding of the biology of healthy and diseased
vessels, the time is ripe for development of novel macromolecular
coatings that can protect the vessel lumen following balloon angioplasty
and promote healthy vascular healing.